Mirtazapin Hexal (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, leading to increased release of norepinephrine, and by antagonising postsynaptic 5‑HT2 and 5‑HT3 receptors, which enhances serotonergic activity. Its additional H1‑histamine antagonism contributes to sedation and appetite stimulation.

The appropriate dose of Mirtazapin Hexal is individualized by the prescribing clinician based on factors such as the severity of depression, patient age, liver function, and response to therapy. Dosage adjustments are made according to clinical judgment and patient tolerance.

The safety of mirtazapine in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Mirtazapin Hexal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mirtazapin Hexal (mirtazapine) belongs to the NaSSA class, whereas SSRIs primarily inhibit serotonin reuptake. Mirtazapine often causes sedation and weight gain, which can be advantageous for patients with insomnia or appetite loss, while SSRIs are generally more activating and have a different side‑effect profile.

Mirtazapin Hexal should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Mirtazapin Hexal is taken orally, usually once daily in the evening to take advantage of its sedative effect. The tablet is swallowed whole with water and should be taken exactly as prescribed by the treating physician.

Serious risks include the potential for agranulocytosis or severe neutropenia, hepatic dysfunction, severe hypersensitivity reactions, and the emergence of suicidal thoughts, especially during the initial weeks of therapy. Combining mirtazapine with other serotonergic agents can also precipitate serotonin syndrome.

Mirtazapin Hexal is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in individuals currently taking monoamine oxidase inhibitors (MAOIs) or who have used an MAOI within the past 14 days. Caution is advised for patients with severe hepatic impairment.